Sterile treatment agent for macromolecular protein and/or nucleic acid as well as preparation method and application of sterile treatment agent
A treatment agent and macromolecular technology, which is applied in the field of aseptic treatment agent for macromolecular protein and/or nucleic acid and its preparation, can solve the problems of heat intolerance, short shelf life, blockage, etc., to improve safety, Strong bactericidal effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] This embodiment provides a kind of aseptic treatment agent for macromolecular protein and / or nucleic acid, and its preparation method comprises the following steps:
[0023] S1. Accurately weigh 0.2 g of 5,5-dimethylhydantoin, 0.2 g of Tween-80, 0.5 g of human α-defensin 5, and 10 g of phosphate buffer solution, and set aside. Among them, the pH of the phosphate buffer solution is 7.2, which is obtained by dissolving 1.546 g of disodium hydrogen phosphate, 0.262 g of sodium dihydrogen phosphate, and 8.768 g of sodium chloride with water and diluting to 1000 mL.
[0024] S2. At room temperature, sequentially add 5,5-dimethylhydantoin, Tween-80, and human α-defensin 5 into the phosphate buffer solution weighed above, and stir with a magnetic stirrer at 500 rpm Stir and mix for 30 minutes at a divided speed to obtain a uniform and stable aseptic treatment agent.
Embodiment 2
[0026] This embodiment provides a kind of aseptic treatment agent for macromolecular protein and / or nucleic acid, and its preparation method comprises the following steps:
[0027] S1. Accurately weigh 1.5g of 5,5-dimethylhydantoin, 1.5g of Tween-80, 5g of human α-defensin 5, and 3g of phosphate buffered saline, and set aside. Among them, the pH of the phosphate buffer solution is 7.2, which is obtained by dissolving 1.546 g of disodium hydrogen phosphate, 0.262 g of sodium dihydrogen phosphate, and 8.768 g of sodium chloride with water and diluting to 1000 mL.
[0028] S2. At room temperature, sequentially add 5,5-dimethylhydantoin, Tween-80, and human α-defensin 5 into the above-mentioned weighed phosphate buffer solution, and use a magnetic stirrer at 1500 rpm Stir and mix for 30 minutes at a divided speed to obtain a uniform and stable aseptic treatment agent.
Embodiment 3
[0030] This embodiment provides a kind of aseptic treatment agent for macromolecular protein and / or nucleic acid, and its preparation method comprises the following steps:
[0031] S1. Accurately weigh 0.3g of 5,5-dimethylhydantoin, 0.3g of Tween-80, 4g of human α-defensin 5, and 9g of phosphate buffer solution, and set aside. Among them, the pH of the phosphate buffer solution is 7.2, which is obtained by dissolving 1.546 g of disodium hydrogen phosphate, 0.262 g of sodium dihydrogen phosphate, and 8.768 g of sodium chloride with water and diluting to 1000 mL.
[0032] S2. At room temperature, sequentially add 5,5-dimethylhydantoin, Tween-80, and human α-defensin 5 into the above-mentioned weighed phosphate buffer solution, and stir with a magnetic stirrer at 800 rpm Stir and mix for 30 minutes at a divided speed to obtain a uniform and stable aseptic treatment agent.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com